Literature DB >> 9510345

Comparison of prostate size in university and Veterans Affairs Health Care System patients with negative prostate biopsies.

M K Terris1, A F Prestigiacomo, T A Stamey.   

Abstract

OBJECTIVES: Many important prostate studies take place at Veterans Affairs hospitals. We have examined whether the patient population at these institutions is comparable to the population presenting for prostate evaluation at university hospitals.
METHODS: We included all patients presenting for transrectal ultrasound (TRUS) and biopsy in whom systematic biopsies failed to reveal prostate cancer at both Stanford University Medical Center (90 patients) and the Palo Alto Veterans Affairs Health Care System (103 patients) from August 1, 1995 to July 31, 1996. Identical techniques and equipment for TRUS examination and prostate size determination were used at both institutions.
RESULTS: There was no significant difference in the age or prostate-specific antigen (PSA) levels of the patients at the two institutions. The mean prostatic volume of the Stanford University patients was 71 cm3 (median 63 cm3), whereas the mean prostatic volume of patients at the Palo Alto Veterans Affairs hospital was 52 cm3 (median 43 cm3), a highly statistically significant difference (P = 0.0009).
CONCLUSIONS: The smaller size of the prostate glands in Veterans Affairs patients may be the result of differences in referral base, socioeconomic factors, or environmental factors. These data may have significance for trials conducted only on the prostates of men who are seen at Veterans Affairs hospitals.

Entities:  

Mesh:

Year:  1998        PMID: 9510345     DOI: 10.1016/s0090-4295(97)00647-x

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  1 in total

1.  Total testosterone density predicts high tumor load and disease reclassification of prostate cancer: results in 144 low-risk patients who underwent radical prostatectomy.

Authors:  Antonio B Porcaro; Alessandro Tafuri; Marco Sebben; Tania Processali; Marco Pirozzi; Aliasger Shakir; Nelia Amigoni; Riccardo Rizzetto; Matteo Brunelli; Filippo Migliorini; Salvatore Siracusano; Walter Artibani
Journal:  Int Urol Nephrol       Date:  2019-08-23       Impact factor: 2.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.